Home/Filings/4/0000899243-22-036697
4//SEC Filing

Beardsley Robert A 4

Accession 0000899243-22-036697

CIK 0001563577other

Filed

Nov 21, 7:00 PM ET

Accepted

Nov 22, 4:05 PM ET

Size

6.8 KB

Accession

0000899243-22-036697

Insider Transaction Report

Form 4
Period: 2022-11-21
Beardsley Robert A
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-11-21$1.07/sh+10,000$10,700108,191 total
  • Exercise/Conversion

    Stock Option

    2022-11-2110,00075,651 total
    Exercise: $1.07Exp: 2022-11-25Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The option has fully vested and is currently exercisable.

Issuer

Galera Therapeutics, Inc.

CIK 0001563577

Entity typeother

Related Parties

1
  • filerCIK 0001310845

Filing Metadata

Form type
4
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 4:05 PM ET
Size
6.8 KB